Big Pharma Split Corp. (PRM)
TSX
Closed
Oct 7, 2026
Day's Range
14.2852 wk Range
11.78Overview - PRM - Big Pharma Split Corp.
Key Statistics
Valuation
P/E (Trailing)
‪12.00‬
Price / Sales (TTM)
‪3.69‬
Profitability
Return on Assets
‪13.82%‬
Return on Equity
‪24.08%‬
Ownership
Shares Outstanding
1.30M
Price stats
50-Day Avg
‪14.54‬
200-Day Avg
‪14.11‬
Dividends
Frequency
Monthly
Market Cap - PRM - Big Pharma Split Corp.
Peers - PRM - Big Pharma Split Corp.
Peer Comparison
Compared with companies in Asset Management listed on TSX.
- PRMTSXBig Pharma Split Corp.20.50MMarket Cap+25.06%52-week change12.00P/E (Trailing)—Profit Margin
- BRKTSXBerkshire Hathaway Inc.1.41TMarket Cap-0.90%52-week change11.86P/E (Trailing)‪22.29%‬Profit Margin
- CLDNTSXCaledonia Investments plc193.60BMarket Cap+1.05%52-week change14.69P/E (Trailing)—Profit Margin
- BLKTSXBLK172.16BMarket Cap-11.29%52-week change25.38P/E (Trailing)‪24.08%‬Profit Margin
- BXTSXBlackstone Inc.133.57BMarket Cap-49.34%52-week change25.00P/E (Trailing)‪22.72%‬Profit Margin
- BNTSXBrookfield Corporation117.51BMarket Cap-20.18%52-week change68.40P/E (Trailing)‪1.77%‬Profit Margin
- BAMTSXBrookfield Asset Management Ltd. Class A Limited Voting Shares102.06BMarket Cap-26.19%52-week change25.96P/E (Trailing)‪48.89%‬Profit Margin
Profile Summary - PRM - Big Pharma Split Corp.
About
Big Pharma Split Corp. is a specialized investment corporation focused on providing investors with exposure to large pharmaceutical companies. Its primary function is to invest in a diversified portfolio of prominent pharmaceutical firms, offering both capital appreciation and dividend income. The corporation…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
